| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.03 (Beat by $0.02) |
| EPS GAAP Actual | $0.03 (Beat by $0.02) |
| Revenue Actual | $0.024169B |
| Revenue Surprise | Beat by $24.169M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.58 | 2.91 | 0.51212 | 0.63932 | 1 |
| Dec 2025 | 0.57361 | 2.95 | 0.47 | 0.69 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.06 | -0.06 | 0.024169B | 2.87% | 24.17M |
| FQ2 2025 (Jun 2025) | 0.0087 | 0.0087 | 0.02531B | -5.6% | 25.31M |
| FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 0.024393B | -26.04% | 24.39M |
| FQ4 2024 (Dec 2024) | -1.21 | -1.21 | -0.056924B | 126.24% | -56.92M |
| FQ3 2024 (Sep 2024) | 0.0121 | 0.0121 | 0.023476B | -10.78% | 23.48M |
| FQ2 2024 (Jun 2024) | 0.0243 | 0.0243 | 0.026727B | -42.75% | 26.73M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.019484B | 100% | 19.48M |
| FQ1 2024 (Mar 2024) | 0.0428 | 0.0428 | 0.030745B | -24.77% | 30.75M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.051 | -- | 0.04660624 | 0.05438882 | 1 |
| FQ3 2027 (Sep 2027) | 0.05175 | -- | 0.04729163 | 0.05518866 | 1 |
| FQ2 2027 (Jun 2027) | 0.046025 | -- | 0.04205985 | 0.04908325 | 1 |
| FQ1 2027 (Mar 2027) | 0.042 | -- | 0.03838161 | 0.0447908 | 1 |
| FQ4 2026 (Oct 2026) | 0.1092 | -- | 0.1029 | 0.1128 | 3 |
| FQ3 2026 (Jul 2026) | 0.1014 | 159.17 | 0.09554876 | 0.10474 | 3 |
| FQ2 2026 (Jun 2026) | 0.1014 | 91.42 | 0.09506488 | 0.10802 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
| FQ3 2027 (Sep 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
| FQ2 2027 (Jun 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
| FQ1 2027 (Mar 2027) | 0.03B | -- | 0.03B | 0.03B | 2 |
| FQ4 2026 (Oct 2026) | 0.05B | -- | 0.04B | 0.05B | 4 |
| FQ3 2026 (Jul 2026) | 0.04B | 46.18 | 0.04B | 0.05B | 4 |
| FQ2 2026 (Jun 2026) | 0.04B | 43.64 | 0.04B | 0.05B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.06 | -0.06 | 100% | |
| FQ2 2025 (Jun 2025) | 0.0087 | 0.0087 | 100% | |
| FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 100% | |
| FQ4 2024 (Dec 2024) | -1.21 | -1.21 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0121 | 0.0121 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0243 | 0.0243 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.0428 | 0.0428 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.02B | $24.17M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.03B | $25.31M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.02B | $24.39M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $-0.06B | $-56.92M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.02B | $23.48M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.03B | $26.73M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.02B | $19.48M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $30.75M | 100% |